Study #2020-0470
WELL-BEING AND QUALITY OF LIFE IN MELANOMA PATIENTS DURING COVID-19 PANDEMIC
MD Anderson Study Status
Enrolling
Treatment Agent
Description
The primary purpose of this study is to gain an understanding of how experiences during the COVID-19 pandemic, regardless of COVID-19 status, may have impacted multiple domains of health-related quality of life and other areas such as COVID-19 specific psychological distress, and disruptions to health care, finances and social interactions. We will also evaluate the extent to which resiliency factors such as social support, perceived benefits under times of stress, and ability to manage stress may buffer associations between COVID-19 experiences and HRQoL. To meet these objectives, we have developed a 10-minute questionnaire that taps into these areas and is based on prior work addressing concerns of other pandemics or national crises. Participants will have previously consented to protocol PA15-0336 and have provided prior lifestyle data. This will allow us to connect the COVID-19 survey data with prior existing data.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
COVID-19 Infection;Melanoma
Study phase:
Physician name:
Lorenzo Cohen
Department:
Palliative Care & Rehabilitation Medicine
For general questions about clinical trials:
1-866-599-0508
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.